Skip to main content
. Author manuscript; available in PMC: 2023 Mar 26.
Published in final edited form as: Sci Transl Med. 2022 Feb 23;14(633):eabj0264. doi: 10.1126/scitranslmed.abj0264

Table 4. EWAS database enrichments.

Ten strongest enrichments within the MRC-IEU EWAS database. FDR is the FDR-corrected P values from a Fisher’s exact test. Effect directions indicate whether the ALS EWAS and trait EWAS effect sizes share the same direction of effect (for example, an opposite direction of effect for BMI indicates that DNA methylation changes at overlapping positions associated with a lower BMI are also associated with a higher ALS risk). EWAS method indicates whether DMPs identified with respective method were enriched for the given trait.

Trait FDR Effect directions EWAS method
BMI 1.36 × 10−9 Opposite LB and MOA
Total serum IgE 1.93 × 10−7 Opposite LB
Triglycerides 4.02 × 10−7 Opposite LB and MOA
Serum triglycerides* 1.32 × 10−5 Opposite LB and MOA
Waist circumference 1.85 × 10−4 Opposite LB and MOA
HDL-c 0.0013 Equal LB and MOA
Hypertriglyceridemic waist 0.0024 Equal LB and MOA
Serum HDL-c* 0.0066 Equal LB and MOA
Fasting glucose 0.0097 Opposite LB and MOA
Atrial fibrillation 0.011 Opposite LB and MOA
*

Note that we adhered to the trait descriptions as provided in the database: serum, plasma, and whole-blood measurements are included as distinct traits (“triglycerides” and “high-density lipoprotein cholesterol” refer to whole-blood measurements).